Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Human Germ Cells Counter Nerve Degeneration

By Biotechdaily staff writers
Posted on 10 Jul 2003
Researchers studying degenerative nerve diseases such as amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) have employed human embryonic germ cells to partially restore mobility in a group of rats with paralyzed hind limbs.

Investigators at Johns Hopkins University (Baltimore, MD, USA) selectively destroyed the nerve cells that control muscles in the hind limbs of a group of laboratory rats by infecting them with a genetically engineered Sindbis virus. More...


The paralyzed mice were separated into three groups, which were treated with either human embryonic germ cells, human cells lacking stem cell properties, or with hamster kidney cells. The results, published in the June 15, 2003, issue of the Journal of Neuroscience, showed that the pluripotent embryonic germ cells established themselves in the rats. The group that received the germ cells partially recovered motor function 12 and 24 weeks after transplantation, whereas the control animals remained paralyzed.

The effect of the germ cells was indirect--due to the production and secretion of transforming growth factor-alpha (TGF-alpha) and brain-derived neurotrophic factor (BDNF)--and not because the germ cells transformed into nervous tissue. These protein factors enhanced the function and survival of the rats' own neurons.

"Our first hypothesis was that functional recovery came from human cells reconstituting the nerve circuits destroyed by the paralysis-inducing virus we gave the rats,” explained first author Dr. Douglas Kerr, assistant professor of neurology at the Johns Hopkins School of Medicine. "Some of the tens of thousands of implanted primitive human stem cells did become nerve cells or the like, but not enough to account for the physical improvements. Instead, these human embryonic germ cells create an environment that protects and helps existing rat neurons--teetering on the brink of death--to survive.”



Related Links:
Johns Hopkins University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
POC Immunoassay Analyzer
Procise DX
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.